Watsonville, CA, United States of America

Gisela T Haringer

This inventor holds 1 USPTO granted patent. Top assignee: Syntex Pharmaceuticals International Limited. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gisela T Haringer. Retrieved from https://idiyas.com/inventor/gisela-t-haringer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gisela T Haringer: Innovator in Respiratory Treatment

Introduction

Gisela T Haringer is a notable inventor based in Watsonville, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of respiratory diseases. Her innovative work has led to the development of a unique crystalline polymorphic form of flunisolide.

Latest Patents

Gisela holds 1 patent for her invention titled "Stable, crystalline flunisolide." This patent discloses a stable crystalline form of flunisolide that is effective in aerosols, such as Freon mixtures. This formulation is particularly valuable in treating respiratory conditions, including bronchial asthma and allergic rhinitis.

Career Highlights

Gisela T Haringer has worked with Syntex Pharmaceuticals International Limited, where she has been instrumental in advancing respiratory treatment options. Her dedication to research and development has positioned her as a key figure in her field.

Collaborations

Throughout her career, Gisela has collaborated with various professionals, including her coworker Richard E Jones. These partnerships have enhanced her research and contributed to her success in the pharmaceutical industry.

Conclusion

Gisela T Haringer's innovative work in developing stable forms of flunisolide showcases her commitment to improving respiratory health. Her contributions continue to impact the treatment of respiratory diseases positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…